Guilin Sanjin Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guilin Sanjin Pharmaceutical Co Ltd with three other
companies in this sector in China:
Shanghai Kaibao Pharmaceutical Company Limited
sales of 1.40 billion Chinese Renmimbi [US$206.30 million]
of which 100%
Xiangxue Pharmaceutical Co Ltd
(1.46 billion Chinese Renmimbi [US$216.34 million]
of which 53%
was Pharmaceutical Manufacturing), and
Guangxi Wuzhou Zhongheng Group, Ltd.
(1.34 billion Chinese Renmimbi [US$198.27 million]
of which 91%
was Pharmaceutical Segment).
Guilin Sanjin Pharmaceutical Co Ltd reported sales of 1.37 billion Chinese Renmimbi (US$202.78 million)
December of 2015.
decrease of 6.4%
versus 2014, when the company's sales were 1.47 billion Chinese Renmimbi.